TAK1 Inhibition in the DFG-Out Conformation
Article first published online: 16 OCT 2013
© 2013 John Wiley & Sons A/S
Chemical Biology & Drug Design
Volume 82, Issue 5, pages 500–505, November 2013
How to Cite
Kilty, I., Green, M. P., Bell, A. S., Brown, D. G., Dodd, P. G., Hewson, C., Hughes, S. J., Phillips, C., Ryckmans, T., Smith, R. T., van Hoorn, W. P., Cohen, P. and Jones, L. H. (2013), TAK1 Inhibition in the DFG-Out Conformation. Chemical Biology & Drug Design, 82: 500–505. doi: 10.1111/cbdd.12169
- Issue published online: 16 OCT 2013
- Article first published online: 16 OCT 2013
- Accepted manuscript online: 7 JUN 2013 11:26AM EST
- Manuscript Accepted: 3 JUN 2013
- Manuscript Revised: 28 MAY 2013
- Manuscript Received: 14 MAR 2013
Figures S1 and S2. Broad kinase selectivity of compounds 1, 7 and 11.
Figure S3. Crystal structures of 7/TAK1 and BIRB-796/p38.
Appendix S1. X-ray data for the crystal structure of 7 with TAK1.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.